Preliminary evaluation of the toxicity of some synthetic furan derivatives in two cell lines and Artemia salina

Journal of Applied Toxicology

Volumn 29, Issue 1, 2009, Pages 36-41

  Amaro, María I ^a   Monasterios, Melina ^a   Avendaño, Milagros ^a   Charris, Jaime ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

BHK21; BST bioassay; Cytotoxicity; Hep 2; Nitrofurans

Indexed keywords

2 [2 ACETYLAMINO 2 [(BENZOTHIAZOLYL SUBSTITUTED)AMINOCARBONYL]VINYL] 5 NITRO FURANE; 2 [2 PHENYLAMINO 2 [BENZOTHIAZOLYLAMINOCARBONYL]VINYL]FURANE; FURAN DERIVATIVE; NITROFURANTOIN; UNCLASSIFIED DRUG;

ARTEMIA SALINA; ARTICLE; BIOASSAY; CELL LINE; CELL STRAIN BHK; CONFIDENCE INTERVAL; CYTOTOXICITY; DRUG STRUCTURE; EVALUATION; HEP 2 CELL; HUMAN; HUMAN CELL; LARYNX CARCINOMA; LC 50; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; SHRIMP;

ANIMALS; ARTEMIA; BIOLOGICAL ASSAY; CELL LINE, TUMOR; CELL SURVIVAL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; HUMANS; MESOCRICETUS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLIUM SALTS; THIAZOLES; TOXICITY TESTS;

ARTEMIA; ARTEMIA SALINA; CRICETINAE;

EID: 58149459141     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1379     Document Type: Article

References (33)

1. Amaro MI, Orfila L, Colman T. 1998. Cytotoxic effects in vitro of the extracts of plants from Annonaceous in tumoral and normal cell. Toxicol. Lett. 95(suppl. 1): 153.
2. Auro A, Sumano H, Ocampo L, Barragán A. 2004. Evaluation of the carcinogenic effects of Furazolidone and its metabolites in two fish species. Pharmacogenomics 4: 24-28.
3. Balls M, Clothier RH. 1992. Cytotoxicity assays for intrinsic toxicity and irritancy. In In Vitro Methods of Toxicology, Watson RR (ed.). CRC Press: Boca Raton, FL; 38.
4. Boelsterli UA, Ho HK, Zhou S, Leow KY. 2006. Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr. Drug Metab. 7: 715-727.
5. Boyd MR. 1980. Biochemical mechanisms in pulmonary toxicity of furan derivatives. Rev. Biochem. Toxicol. 2: 71-102.
6. Charris J, Monasterios M, Domínguez J, Infante W, De Castro N. 2002. Synthesis of some 5-nitro-2-furfurylidene derivates and their antibacterial and antifugal activities. Heterocycl. Commun. 8: 275-280.
7. De Angelis I, Rossi L, Pedersen JZ, Vignoli AL, Vincentini O, Hoogenboom LAP, Polman THG, Stammati A, Zucco F. 1999. Metabolism of furazolidone: alternative pathways and modes of toxicity in different cell lines. Xenobiotica 11: 1157-1169.
8. Denizot F, Lang R. 1986. Rapid colorimetric assay for cell growth and survival modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89: 271-277.
9. Dodd MC, Stillman WB. 1944. The in vitro bacteriostatic action of some simple furan derivatives. J. Pharmac. Exp. Ther. 82: 11-18.
10. Finney DJ. 1971. Probit Analysis, 3rd edn. Cambridge University Press: Cambridge.
11. Graham DY, Osato MS, Hoffman J, Opekun AR, Anderseon SY, El-Zimaitry HM. 2000. Furazolidone combination therapies for Helicobacter pylori infection in United States. Aliment. Pharm. Ther. 14: 211-215.
12. Gringauz A. 1997. Introduction to Medicinal Chemistry; How Drugs Act and Why. Willey-VCH: New York.
13. Hershey DR. 2004. Brine shrimp 'bioassay' problems. Am. Biol. Teach. 66: 474-475.
14. Huveneers-Oorsprong MBM, Hoogenboom LAP, Kuiper HA. 1997. The use of the MTT test for determining the cytotoxicity of veterinary drugs in pig hepatocytes Toxicol. in Vitro 11: 385-392.
15. Isanbor C, O'Hagan D. 2006. Fluorine in medicinal chemistry: a review of anticancer agents. J. Fluorine Chem. 127: 303-319.
16. Kivçak B, Mert TH, Öztürk T. 2002. Antimicrobial and cytotoxic activities of Ceratonia siliqua L. extracts. Turk. J. Biol. 26: 197-200.
17. Macri A, Stazi AV, Dojmi Di Delupis G. 1988. Acute toxicity of furazolidone on A. salina, Daphnia magna and Culex pipiens molestus larvae. Ecotox. Envirom. Safe. 16: 90-91.
18. Matthews RS. 1995. Artemia salina as a test organism for measuring superoxide-mediated toxicity. Free Radical Biol. Med. 18: 919-922.
19. McGregor DB, Edwars I, Wolf CR, Ferrester LM and Caspary WJ. 1991. Endogenus xenobiotic levels in mammalian cells. Mutat. Res. 261: 29-39.
20. McLaughlin JL, Chang Ch-J, Smith D. 1991. In Studies in Natural Products Chemistry, Vol. 9, Atta-ur-Rahman (ed.). Elsevier Science: Amsterdam; 385.
21. McPherson I, Stoker M. 1962. Polyoma transformation of hamster cell clones an investigation of genetic factors affecting competence. Virology. 16: 147-151.
22. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. 1982. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med. 45: 31-34.
23. Monasterios M, Escorche M, Avendaño M. 2005. Conformational analysis, electronic properties and molecular electrostatic potential of nitrofurans derivatives with antibacterial activity. J. Mol. Struct. 748: 49-55.
24. Monasterios M, Avendaño M, Amaro MI, Infante W, Charris J. 2006. Relation between electrostatic molecular potential, several electronic properties and antibacterial activity of some synthetic furan derivatives. J. Mol. Struct. 798: 102-108.
25. Moore AE, Sabachewsky L, Toolan H. 1955. Culture characteristics of four permanent human cancer cell lines. Cancer Res. 15: 598-602.
26. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63.
27. Olive PL, McCalla DR. 1975. Damage to mammalian cell DNA by nitrofurans. Cancer Res. 35: 781-784.
28. Olive PL, McCalla DR. 1977. Cytotoxicity and DNA damage to mammalian cell by nitrofurans. Chem. Biol. Interact. 16: 223-233.
29. Shahverdi AR, Fazeli MR, Raffi F, Kakavand M, Jamalifar H, Hamedi XX. 2003. Inhibition of nitrofurantoin reduction by menthol leads to enhanced antimicrobial activity. J. Chemother. 15: 449-453.
30. Stammati A, Zampagloni F, Zucco F. 1997. Furadaltone cytotoxicity on three cell lines in the presence or absence of DMSO: comparison with furazolidone. Cell Biol. Toxicol. 13: 125-130.
31. Stammati A, Nebbia C, De Angelis I, Albo AG, Carletti M, Rebecchi C, Zampagloni F, Dacasto M. 2005. Effects of malachite green (MG) and its major metabolite leucomalachite green (LMG), in two human cell lines. Toxicol. in Vitro 19: 853-858.
32. Toropchin VI, Kabelskii VV, Babitskii VL, Savchenko NA, Tereshchenl VV. 2003. Treatment of patients with acute pneumonia. Lik Sprava 3-4: 72-74.
33. Zhanel GG, Hoban DJ, Karlowsky JA. 2001. Nitrofurantoin is active against vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45: 324-326.